United Kingdom, January 18: With the onset of increasing issues of people getting affected by new disease and health issues, researchers are on the verge of discovering methods to deal with these sicknesses. Naturally, our lives would be much simpler if we could just get one "universal" flu vaccine shot that could protect against most strains for a longer period of time. Now it looks like Vaccitech, a private spinoff of Oxford University in the United Kingdom, is getting closer and closer to that goal.
Imbibing a subtle goal that would have massive benefits for global public health and eliminate our need for annual injections, researchers of a company in the UK is currently undergoing a clinical trial of what could become the first universal flu vaccine in the world. It is estimated that currently our planet is facing its worst flu season in years, in comparison to the seasonal vaccine that's proved to be less effective than usual.